C4 Therapeutics Inc (CCCC): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 12,857 US Dollar | 6 | 2 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 123.025.136 | 34,93 | 17,84 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name C4 Therapeutics Inc
Mitarbeiter 104
Handelsplatz NASDAQ
Ticker Symbol CCCC
IPO Datum 2020-10-02
Adresse 490 Arsenal Way, Watertown, MA, United States, 02472
Webseite https://www.c4therapeutics.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Andrew J. Hirsch M.B.A. | CEO, President & Director |
| 2 | Dr. Kenneth C. Anderson M.D., Ph.D. | Co-Founder, Independent Director & Member of Scientific Advisory Board |
| 3 | Ms. Kendra R. Adams | Principal Accounting Officer, CFO, Head of Corporate Affairs & Treasurer |
| 4 | Dr. Leonard M. J. Reyno M.D. | Chief Medical Officer |
| 5 | Dr. Nathanael S. Gray Ph.D. | Co-Founder & Member of Scientific Advisory Board |
| 6 | Ms. Courtney Solberg | Senior Manager of Investor Relations |
| 7 | Ms. Kelly A. Schick | Chief People Officer |
| 8 | Dr. Isabel Chiu Ph.D. | Senior Vice President of Strategic Alliances & Business Development |
| 9 | Dr. Christopher Nasveschuk | Senior Vice President of Chemistry |
| 10 | Mr. Roy Pollock Ph.D. | Senior Vice President of Biological Sciences |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Morgan Stanley - Brokerage Accounts | 7,21% | 29,74 Mio. USD |
| 2 | RA Capital Management, LLC | 6,50% | 26,83 Mio. USD |
| 3 | BlackRock Inc | 6,42% | 26,49 Mio. USD |
| 4 | Lynx1 Capital Management, LP | 5,96% | 24,57 Mio. USD |
| 5 | Squadron Capital Management LLC | 5,85% | 24,15 Mio. USD |
| 6 | Bain Capital Life Sciences Investors, LLC | 5,83% | 24,06 Mio. USD |
| 7 | JPMorgan Chase & Co | 3,86% | 15,92 Mio. USD |
| 8 | Vanguard Capital Management, LLC | 3,59% | 14,82 Mio. USD |
| 9 | Citadel Advisors Llc | 3,40% | 14,05 Mio. USD |
| 10 | The Goldman Sachs Group Inc | 2,87% | 11,84 Mio. USD |
| 11 | Wasatch Advisors LP | 2,86% | 11,82 Mio. USD |
| 12 | Two Sigma Investments LLC | 2,82% | 11,64 Mio. USD |
| 13 | Soleus Capital Management, L.P. | 2,75% | 11,33 Mio. USD |
| 14 | SILVERARC CAPITAL MANAGEMENT, LLC | 2,46% | 10,17 Mio. USD |
| 15 | Bank of America Corp | 2,16% | 8,91 Mio. USD |
| 16 | Geode Capital Management, LLC | 2,05% | 8,46 Mio. USD |
| 17 | Ikarian Capital, LLC | 1,98% | 8,16 Mio. USD |
| 18 | State Street Corp | 1,72% | 7,10 Mio. USD |
| 19 | Acadian Asset Management LLC | 1,47% | 6,06 Mio. USD |
| 20 | Candriam Luxembourg S.C.A. | 1,46% | 6,03 Mio. USD |